Question

I am a breastfeeding mother and i want to know if it is safe to use EINECS 229-374-5? Is EINECS 229-374-5 safe for nursing mother and child? Does EINECS 229-374-5 extracts into breast milk? Does EINECS 229-374-5 has any long term or short term side effects on infants? Can EINECS 229-374-5 influence milk supply or can EINECS 229-374-5 decrease milk supply in lactating mothers?

EINECS 229-374-5 lactation summary

EINECS 229-374-5 is safe in breastfeeding
  • DrLact safety Score for EINECS 229-374-5 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of EINECS 229-374-5 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that EINECS 229-374-5 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of EINECS 229-374-5 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About EINECS 229-374-5 usage in lactation

It reduces blood viscosity. It is a methyl-xanthine drug.

Answer by DrLact: About EINECS 229-374-5 usage in lactation

Limited data indicate that EINECS 229-374-5 is poorly excreted into breastmilk. It would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months.

Alternate Drugs

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.